edison tv
Investment Companies
“Edison is the go-to for a new investor to get full understanding of the investment case and business. Edison’s distribution reaches investors that we want to connect with directly.”
Associated equity: e-therapeutics
Edison Investment Research is terminating coverage on e-therapeutics (ETX). Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be considered redundant.
e-therapeutics — 2 videos in collection
e-therapeutics is a UK biotech company using proprietary computational biology and RNAi platforms to discover novel disease targets and therapies. The company is specifically focused on leveraging its expertise to design treatments for hepatocyte-associated disease indications (not restricted to diseases in the liver) with untapped, novel targets, providing scope for new treatments to have a unique offering.
In partnership with Curation Connect, we are pleased to share the e-therapeutics showcase, which curates a range of different Edison, company and industry material for investors to learn more about this stock.
Get access to the very latest content matched to your personal investment style.